"Measure, compare, locate. That was how we recorded the genetic sequences of every patient with hereditary diseases, hoping to find a solution among them."
As they walked, Harry showed Peter Osborn's "Biological Era" project.
Compared to a close friend, Peter from this world felt more like a younger brother to Harry.
Having lived two lives, Harry's mental age made it difficult for him to see this high schooler, Peter Parker, as one of the guys.
"I know about this—gene therapy. A lot of biotech companies are working on it." Peter clearly knew something about genetics.
In truth, research into hereditary diseases had never stopped, and Osborn itself had conducted related research.
"Looks like you know quite a bit about it." As they walked, Harry pointed at a case displayed on one of the screens.
"Crigler-Najjar syndrome, also known as congenital glucuronyl transferase deficiency or congenital non-obstructive non-hemolytic jaundice. This genetic disease has two types."
"Type I was reported in 1952. It is autosomal recessive, and the parents are often related by blood. I won't get into all the technical details. In short, the patient's liver cells lack a certain enzyme, triggering a series of illnesses."
The patient in the image was a young child, his body bent backward like a bow, looking to be in tremendous pain.
"Type II was reported in 1962. It is autosomal dominant, and the parents are rarely related by blood. It is likewise caused by abnormal liver cell function."
"The Osborn Group has developed a Gene agent that can gradually modify the defective genes through long-term use, allowing patients to return to normal."
"Of course, there is another treatment—replace the liver. The Osborn Group also possesses Artificial Liver technology."
Peter's face was full of admiration.
He had once thought Iron Man was cool, that one